(The H4-Index of Lancet is 183. The table below lists those papers that are above that threshold based on CrossRef citation counts. The publications cover those that have been published in the past four years, i.e., from 2019-03-01 to 2023-03-01.)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China29094
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study12587
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding7074
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global B6006
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster5699
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 20154207
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease3975
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 20193865
Food in the Anthropocene: the EAT–Lancet Commission on healthy diets from sustainable food systems3713
Hepatocellular carcinoma3236
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies3035
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study2981
National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants2876
National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications2816
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 20002541
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years2460
Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 20172144
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants2112
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 20192106
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis1617
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials1613
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 tri1552
Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 20171506
Colorectal cancer1498
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study1386
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury1357
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 st1202
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial1174
The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report1098
The World report on ageing and health: a policy framework for healthy ageing1061
Nasopharyngeal carcinoma1059
Oral diseases: a global public health challenge1059
2019-nCoV epidemic: address mental health care to empower society1048
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial988
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease949
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or g928
Cervical cancer896
50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study866
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib827
Frailty: implications for clinical practice and public health824
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study809
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial793
Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study789
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis726
National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million partic722
Carbohydrate quality and human health: a series of systematic reviews and meta-analyses706
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial695
Epithelial ovarian cancer688
The 2019 report of The Lancet Countdown on health and climate change: ensuring that the health of a child born today is not defined by a changing climate673
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis645
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)623
2019-nCoV transmission through the ocular surface must not be ignored620
Epilepsy in adults617
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial604
Acute kidney injury596
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial586
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial557
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind,547
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial543
Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study526
An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction523
Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study520
Child undernutrition, tropical enteropathy, toilets, and handwashing511
Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019500
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label500
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants492
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis466
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials461
Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study453
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global 451
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospect446
New WHO prevalence estimates of mental disorders in conflict settings: a systematic review and meta-analysis438
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial433
Management of frailty: opportunities, challenges, and future directions430
On the use of corticosteroids for 2019-nCoV pneumonia423
National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis403
Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial396
Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study395
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study391
National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million partic385
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial385
Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study384
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial376
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial371
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b tri369
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials369
Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching358
Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial357
10 years of health-care reform in China: progress and gaps in Universal Health Coverage354
BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study353
Reporting of artificial intelligence prediction models349
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study349
Neurodevelopmental outcome at 5 years of age after general anaesthesia or awake-regional anaesthesia in infancy (GAS): an international, multicentre, randomised, controlled equivalence trial345
Gender inequality and restrictive gender norms: framing the challenges to health340
Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study335
Incidence of infective endocarditis in England, 2000–13: a secular trend, interrupted time-series analysis333
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre,327
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial321
Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence320
Brazil's unified health system: the first 30 years and prospects for the future317
Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study314
Ending the neglect of global oral health: time for radical action313
Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause301
Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a random299
Transition from acute to chronic pain after surgery297
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial294
Acute liver failure292
Health in South Africa: changes and challenges since 2009291
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled290
Reducing mortality from 2019-nCoV: host-directed therapies should be an option282
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial280
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, ph277
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial276
Antibody–drug conjugates for cancer275
Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS): a multicentre, randomised, open label, blinded outcome, non-inferiority trial274
Large outbreak of clinical cholera due to Vibrio cholerae non-01 in Bangladesh272
Global patterns of opioid use and dependence: harms to populations, interventions, and future action272
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial267
Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burd265
Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study258
Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data250
Antibiotic allergy247
Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial246
Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial246
Prevalence, risk factors, and management of asthma in China: a national cross-sectional study243
How long does a hip replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up241
Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial241
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial240
Are gender gaps due to evaluations of the applicant or the science? A natural experiment at a national funding agency238
Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China238
Novel paradigms in systemic lupus erythematosus237
How long does a knee replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up236
Autosomal dominant polycystic kidney disease235
Alcohol use disorders232
A comprehensive analysis of mortality-related health metrics associated with mental disorders: a nationwide, register-based cohort study229
Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial228
Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial227
Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys227
First experience of COVID-19 screening of health-care workers in England225
The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults224
Ebola virus disease223
Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety222
Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial222
Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000–17: a spatial and temporal modelling study220
Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial218
Hepatitis C217
Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses217
Perioperative opioid analgesia—when is enough too much? A review of opioid-induced tolerance and hyperalgesia216
Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study211
Gender equality in science, medicine, and global health: where are we at and why does it matter?209
Emerging understandings of 2019-nCoV208
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial206
Human infection with avian influenza A H7N9 virus: an assessment of clinical severity204
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority tr202
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from 202
2019-nCoV, fake news, and racism201
Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995–2050201
Inappropriate opioid prescription after surgery200
Management of opioid use disorder in the USA: present status and future directions199
Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study198
Management strategies and future directions for systemic lupus erythematosus in adults197
Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases197
How women are treated during facility-based childbirth in four countries: a cross-sectional study with labour observations and community-based surveys196
Global burden of postoperative death195
Disappearing, displaced, and undervalued: a call to action for Indigenous health worldwide194
Robot assisted training for the upper limb after stroke (RATULS): a multicentre randomised controlled trial194
Five insights from the Global Burden of Disease Study 2019194
Building a tuberculosis-free world: The Lancet Commission on tuberculosis193
External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a r191
Detecting and biotyping Vibrio cholerae 01 with multiplex polymerase chain reaction188
Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial188
Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study188
HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label tria187
Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial183
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study183